Preparation and characterization of hCG-loaded polylactide or poly(lactide-co-glycolide) microspheres using a modified water-in-oil-in-water (w/o/w) emulsion solvent evaporation technique.
A modified w/o/w emulsion solvent evaporation technique was adopted to prepare human Chorionic Gonadotropin (hCG)-loaded polylactide (PLA) or poly(lactide-co-glycolide) (PLGA) microspheres. The effects of preparative parameters, such as stirring rate, polymer MW and concentration, and the composition of both the inner aqueous phase and oil phase etc., on hCG entrapment efficiency and microsphere characteristics were investigated. It was found that by adding 20% glycerol into the inner aqueous phase and 40% acetone into the oil phase, smooth microspheres approximately 1 microm in diameter could be produced with high hCG entrapment efficiency (>90%). In vitro release test showed a burst release of hCG from PLGA (75:25) microspheres, followed by sustained release of 55% hCG over 2 months. The initial hCG burst from PLGA microspheres increased with the glycerol concentration in the inner aqueous phase, but decreased to a low value (ca. 20%) with the addition of acetone into the oil phase, which could be attributed to the associated changes in surface morphology of the microspheres. In vivo experiments demonstrated that a single shot of hCG-loaded PLGA microspheres could produce a comparable antibody response with the inoculation of free hCG four times.
Zhu
K J
KJ
Department of Polymer Science and Engineering, Zheijang University, Hangzhou, PR China. kjzhu@ipsm.zju.edu.cn
Jiang
H L
HL
Du
X Y
XY
Wang
J
J
Xu
W X
WX
Liu
S F
SF
D000096:Acetone / Q000737:chemistry; D000818:Animals; D002626:Chemistry, Pharmaceutical; D006063:Chorionic Gonadotropin / Q000008:administration & dosage / Q000737:chemistry* / Q000276:immunology; D004655:Emulsions; D005260:Female; D005990:Glycerol / Q000737:chemistry; D006801:Humans; D007114:Immunization; D007074:Immunoglobulin G / Q000096:biosynthesis / Q000276:immunology; D007700:Kinetics; D019344:Lactic Acid / Q000008:administration & dosage / Q000737:chemistry*; D051379:Mice; D008863:Microspheres; D009821:Oils / Q000737:chemistry; D010316:Particle Size; D011091:Polyesters / Q000008:administration & dosage / Q000737:chemistry; D011100:Polyglycolic Acid / Q000008:administration & dosage / Q000737:chemistry*; D000077182:Polylactic Acid-Polyglycolic Acid Copolymer; D011108:Polymers / Q000008:administration & dosage / Q000737:chemistry*; D051381:Rats; D012997:Solvents; D014835:Volatilization; D014867:Water / Q000737:chemistry
D006063:Chorionic Gonadotropin; D004655:Emulsions; D007074:Immunoglobulin G; D009821:Oils; D011091:Polyesters; D011108:Polymers; D012997:Solvents; D014867:Water; D000096:Acetone; D000077182:Polylactic Acid-Polyglycolic Acid Copolymer; D011100:Polyglycolic Acid; D019344:Lactic Acid; C033616:poly(lactide); D005990:Glycerol